(Q35745789)

English

Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology

scientific article published on October 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology (English)

1 reference

Europe PubMed Central

10 August 2017

author name string

E Dublin

1

1 reference

Europe PubMed Central

10 August 2017

A Hanby

2

1 reference

Europe PubMed Central

10 August 2017

N K Patel

3

1 reference

Europe PubMed Central

10 August 2017

R Liebman

4

1 reference

Europe PubMed Central

10 August 2017

D Barnes

5

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

1 October 2000

1 reference

Europe PubMed Central

10 August 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

10 August 2017

157

1 reference

Europe PubMed Central

10 August 2017

4

1 reference

Europe PubMed Central

10 August 2017

1219-1227

1 reference

Europe PubMed Central

10 August 2017

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Urokinase plasminogen activator: a prognostic marker in multiple types of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

The urokinase plasminogen activator system as a target for prognostic studies in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Prognostic impact of tumor biological factors on survival in node-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Urokinase receptor localization in breast cancer and benign lesions assessed by in situ hybridization and immunohistochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Ductal carcinoma in situ: a proposal for a new classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Plasminogen activators, tissue degradation, and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

The role of stromal cells in tumor metastasis: a new link

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

The role of proteolytic enzymes in cancer invasion and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

12 July 2018

Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

25 September 2018

Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

25 September 2018

Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850159

25 September 2018

Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964637-8

7 January 2021

Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964637-8

7 January 2021

Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964637-8

7 January 2021

Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964637-8

7 January 2021

Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964637-8

7 January 2021

Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964637-8

7 January 2021

Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964637-8

7 January 2021

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964637-8

7 January 2021

Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11021826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11021826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11021826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase type plasminogen activator receptor is a novel prognostic factor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11021826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0002-9440(10)64637-8

1 reference

Europe PubMed Central

10 August 2017

release_jlwkougewrg63fpbmrtf46nyyq

1 reference

https://api.fatcat.wiki/v0/release/jlwkougewrg63fpbmrtf46nyyq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35745789&oldid=1844408695"